Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy

Hecht M, Eckstein M, Kallies A, Von Der Grun J, Illmer T, Klautke G, Laban S, Hautmann M, Brunner T, Tamaskovics B, Hinke A, Zhou J, Frey B, Donaubauer AJ, Becker I, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Gostian AO, Fietkau R (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: KARGER

City/Town: BASEL

Pages Range: 131-131

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hecht, M., Eckstein, M., Kallies, A., Von Der Grun, J., Illmer, T., Klautke, G.,... Fietkau, R. (2022). Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy. In ONCOLOGY RESEARCH AND TREATMENT (pp. 131-131). BASEL: KARGER.

MLA:

Hecht, Markus, et al. "Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 131-131.

BibTeX: Download